External Quality Assessment for Cardiac Markers in Medical Practice

Cardiac markers, especially Troponin I (cTnI) and Troponin T (cTnT), are critical measurements in acute coronary syndrome.  Most authorities recommend that these measurements are carefully quality controlled.  UKNEQAS-Cardiac Marker schemes meet the external quality assessment (EQA) requirements of members by providing monthly distributions of samples with clinically relevant levels of these markers. 

UKNEQAS-Cardiac Markers is provided by a not-for-profit Health Service Scotland organisation.  It is fully accredited by Clinical Pathology Accreditation (UK) Ltd (CPA) and is a full member of UKNEQAS. The cardiac troponin EQA schemes have been in operation since 1998. 

 

The following EQA schemes are all CPA accredited:

Laboratory Based Schemes:  cTnI, cTnT, CKMB, Myoglobin, B-type Natriuretic Peptide (BNP) and NT-proB-type Natriuretic Peptide (NT-proBNP).
Point of Care Schemes - cTnI, cTnT, CKMB, Myoglobin, BNP and NT-proBNP.
 
We welcome new participants from any clinical/research laboratory or point of care provider.

Please check the NEWS page for scheme communications.

Cardiac Marker Dialogues Meeting on the 13th October 2011 in Glasgow was regarded by delegates as another success.

If you do not participate at present and wish further information on the schemes we provide please contact us.

Registered participants can access further information on the following via the members area.

• Electronic Reporting of results
• Electronic Reports (pdf)
• Scheme annual reports
• Interpretative Excercise reports
• Questionnaires
• Reports from presentations at participant meetings
• Method Reports
• Information on distribution dates
• Change contact details
• Reset or change password
• Participants' News Blog 

 To assess the schemes service to participants please answer relevant questionnaires when requested.

 

Page last updated on: 18/10/2011 19:25:26